Exploring 2,4-DMA. To explore a different substance…

Names:
2,4-DMA · 2,4-Dimethoxyamphetamine
IUPAC name:
1-(2,4-Dimethoxyphenyl)propan-2-amine
ID: 53 · Formula: C11H17NO2 · Molecular weight: 195.258
InChI: InChI=1S/C11H17NO2/c1-8(12)6-9-4-5-10(13-2)7-11(9)14-3/h4-5,7-8H,6,12H2,1-3H3

Bailey, K; Legauld, D; Verner, D. Spectroscopic and chromatographic identification of dimethoxyamphetamines. J. Assoc. Off. Anal. Chem., 1974, 57 (1), 70–78. 426 kB.

Glennon, RA; Rosecrans, JA; Young, R. Behavioral properties of psychoactive phenylisopropylamines in rats. Eur. J. Pharmacol., 17 Dec 1981, 76 (4), 353–360. 964 kB. http://dx.doi.org/10.1016/0014-2999(81)90106-0

Thakur, M; Thakur, A; Khadikar, PV. QSAR studies on psychotomimetic phenylalkylamines. Bioorg. Med. Chem., 15 Feb 2004, 12 (4), 825–831. 323 kB. http://dx.doi.org/10.1016/j.bmc.2003.10.027

Shulgin, AT. Psychotomimetic drugs: structure-activity relationships. In Handbook of Psychopharmacology: Stimulants; Iversen, LL; Iversen, SD; Snyder, SH, Eds., Plenum Press, New York, 1978; Vol. 11, pp 243–333. 2.6 MB. http://dx.doi.org/10.1007/978-1-4757-0510-2_6 Rhodium.

Antun, F; Smythies, JR; Benington, F; Morin, RD; Barfknecht, CF; Nichols, DE. Native fluorescence and hallucinogenic potency of some amphetamines. Experientia, 15 Jan 1971, 27 (1), 62–63. 248 kB. http://dx.doi.org/10.1007/BF02137743

Bailey, K; Legault, D. 13C NMR spectra and structure of mono-, di- and trimethoxyphenylethylamines and amphetamines. Org. Magn. Resonance, 1 Jun 1983, 21 (6), 391–396. 680 kB. http://dx.doi.org/10.1002/omr.1270210611

Glennon, RA; Liebowitz, SM; Anderson, GM. Serotonin receptor affinities of psychoactive phenalkylamine analogues. J. Med. Chem., 1 Mar 1980, 23 (3), 294–299. 844 kB. http://dx.doi.org/10.1021/jm00177a017

Altun, A; Golcuk, K; Kumru, M; Jalbout, AF. Electron-conformation study for the structure-hallucinogenic activity relationships of phenylalkylamines. Bioorg. Med. Chem., 1 Dec 2003, 11 (24), 3861–3868. 577 kB. http://dx.doi.org/10.1016/S0968-0896(03)00437-1

Glennon, RA; Raghupathi, R; Bartyzel, P; Teitler, M; Leonhardt, S. Binding of phenylalkylamine derivatives at 5-HT1C and 5-HT2 serotonin receptors: evidence for a lack of selectivity. J. Med. Chem., 1 Feb 1992, 35 (4), 734–740. 1.1 MB. http://dx.doi.org/10.1021/jm00082a014

Domelsmith, LN; Eaton, TA; Houk, KN; Anderson, GM; Glennon, RA; Shulgin, AT; Castagnoli, N; Kollman, PA. Photoelectron spectra of psychotropic drugs. 6. Relationships between physical properties and pharmacological actions of amphetamine analogues. J. Med. Chem., 1 Jan 1981, 24 (12), 1414–1421. 963 kB. http://dx.doi.org/10.1021/jm00144a009

Shulgin, AT. Chemistry and structure-activity relationships of the psychotomimetics. In Psychotomimetic Drugs; Efron, DH, Ed., Raven Press, New York, 1970; pp 21–41. 8.6 MB.

Shulgin, AT; Sargent, T; Naranjo, C. Structure-activity relationships of one-ring psychotomimetics. Nature, 1 Jan 1969, 221, 537–541. 537 kB. http://dx.doi.org/10.1038/221537a0

Scorza, M; Carrau, C; Silveira, R; Zapata-Torres, G; Cassels, BK; Reyes-Parada, M. Monoamine oxidase inhibitory properties of some methoxylated and alkylthio amphetamine derivatives. Biochem. Pharmacol., 15 Dec 1997, 54 (12), 1361–1369. 697 kB. http://dx.doi.org/10.1016/S0006-2952(97)00405-X

2,4-DNNA
2,4-DMMA
2155
2156
2157
2158
2159
2,4-DMA-NBOMe
2,4-DMPEA
4C-2,4-DMPEA
PMA
2,4-HMA
TMA-3
3,2,4-DOB
3-Me-2,4-DOM
3,2,4-DOET
2-MA · 2-Methoxyamphetamine
2,4-MMA · 5-H-DOM
2332
4-Cl-2-MA
4-Br-2-MA
4-I-2-MA
2-MTFMA
m-DOB · META-DOB
m-DOT · META-DOT
MME
TMA-2
m-DOM · 5-DOM
META-DOF
META-DOI
5-NH2-2,4-DMA
5,2,4-DOET
TMA-6
6-Me-2,4-DOM · Z-7.1
Osmorrhizole
1012
Nothosmyrnol
2,4-DMA-βk
2,3-DMBZP · 2,4-DMBZP
2C-D
DESOXY
2,5-DMA
3,4-DMA
MEPEA
3,5-DMA
2,3-DMA
2,6-DMA
MM-GEA
N-Me-2,5-DMPEA · 25H-NMe
2,5-MH-MMA
2-DES-Me-DOM · 2-DM-DOM
5-DES-Me-DOM · 5-DM-DOM
4-Me-2,6-DMPEA · ψ-2C-D
2407
4-Ethoxynorephedrine
BO3MM
BO3ME
BO3MA
BO3E
N-Me-DMPEA-2
2,3-EMPEA
N-Me-DMPEA-3
2,4-EMPEA
Coryneine
N,N-Me-DHA
DHEA
MHMA
MH-α-Et-PEA
HMMA
β-Me-DMPEA
N-Me-DMPEA
EMPEA
β,2-HO-5,N-DMeA
β-HO-N-Me-2-M-5-MePEA
β-HO-2-M-5-MeA
N,N-Me-2,5-HMPEA
β-Me-2,5-DMPEA
N-Me-3,5-DMPEA
N-Me-2,6-DMPEA
6-Me-2,4-DMPEA
iso-2C-D
HMP
homo-3,4-DMPEA
N-MeO-PMA
2,4-DNNA
2,4-DMMA
2155
2156
2157
2158
2159
2,4-DMA-NBOMe
2,4-DMPEA
4C-2,4-DMPEA
PMA
2,4-HMA
TMA-3
3,2,4-DOB
3-Me-2,4-DOM
3,2,4-DOET
2-MA · 2-Methoxyamphetamine
2,4-MMA · 5-H-DOM
2332
4-Cl-2-MA
4-Br-2-MA
4-I-2-MA
2-MTFMA
m-DOB · META-DOB
m-DOT · META-DOT
MME
TMA-2
m-DOM · 5-DOM
META-DOF
META-DOI
5-NH2-2,4-DMA
5,2,4-DOET
TMA-6
6-Me-2,4-DOM · Z-7.1
Osmorrhizole
1012
Nothosmyrnol
2,4-DMA-βk
2,3-DMBZP · 2,4-DMBZP
2C-D
DESOXY
2,5-DMA
3,4-DMA
MEPEA
3,5-DMA
2,3-DMA
2,6-DMA
MM-GEA
N-Me-2,5-DMPEA · 25H-NMe
2,5-MH-MMA
2-DES-Me-DOM · 2-DM-DOM
5-DES-Me-DOM · 5-DM-DOM
4-Me-2,6-DMPEA · ψ-2C-D
2407
4-Ethoxynorephedrine
BO3MM
BO3ME
BO3MA
BO3E
N-Me-DMPEA-2
2,3-EMPEA
N-Me-DMPEA-3
2,4-EMPEA
Coryneine
N,N-Me-DHA
DHEA
MHMA
MH-α-Et-PEA
HMMA
β-Me-DMPEA
N-Me-DMPEA
EMPEA
β,2-HO-5,N-DMeA
β-HO-N-Me-2-M-5-MePEA
β-HO-2-M-5-MeA
N,N-Me-2,5-HMPEA
β-Me-2,5-DMPEA
N-Me-3,5-DMPEA
N-Me-2,6-DMPEA
6-Me-2,4-DMPEA
iso-2C-D
HMP
homo-3,4-DMPEA
N-MeO-PMA
21 September 2017 · Creative Commons BY-NC-SA ·